Interesting that Nexium (number 2 last year) has dropped completely out of the top 10. Insurance company muscle finally having some impact (forcing switches to comparable generics). Here's data for the top 100 for the last few years: http://cbc.arizona.edu/njardarson/group/top-pharmaceuticals-poster Peter